ArticleApplied biochemistry and biotechnology2025

Durvalumab and T-DXd Synergistically Promote Apoptosis of Cholangiocarcinoma Cells by Downregulating EGR1 Expression Through Inhibiting P38 MAPK Pathway.

Yuepeng WangPubMed ↗Publisher ↗

No numbers read from the abstract.